Document is current
Any future updates will be listed below
-
Authors
Ow, Thomas J.
Mehta, Vikas
Kim, Seokhwa
Vakil, Mayand
Friedmann, Patricia
In, Haejin
-
Funding
Funding for this research was provided by:
National Center for Advancing Translational Sciences (UL1TR001073)
National Institute for Dental and Craniofacial Research (K23 DE027425)
National Cancer Institute (2K12 CA132783-06)
- License Information
-
More Information
Article History
Received: 13 August 2021
Accepted: 15 November 2021
First Online: 23 January 2022
Disclosures
: Dr. T. J. Ow is the site Principal Investigator for a phase 0 study supported by Presage Biosceinces, Inc., with sub-studies sponsored by Takeda (Millenium Pharmaceuticals, Inc.) and Bristol Myers Squibb. The phase 0 study is not focused on medullary thyroid carcinoma or radiation treatment. The remaining authors have no conflicts of interest.
